Literature DB >> 6805014

Repeated administration of subconvulsant doses of GABA antagonist drugs. II. Effect on monoamine-mediated behaviour.

P J Cowen, D J Nutt, C C Batts, A R Green, D J Heal.   

Abstract

The effect on monoamine-medical behaviour of repeated daily subconvulsive doses of the GABA antagonist drugs pentylenetetrazol (PTZ) (30 mg/kg for 8 days), picrotoxin (5 mg/kg for 4 days) and bicuculline (3.5 mg/kg for 16 days) was investigated. None of the drugs, administered chronically, increased behavioural responses to the 5-hydroxytryptamine agonist quipazine (25 mg/kg), and neither picrotoxin nor bicuculline altered the locomotor response to the dopamine agonist apomorphine (AP) (0.1 mg/kg). By contrast, repeated doses of PTZ increased the locomotor response to AP, and also increased circling responses to both AP (0.5 mg/kg) and methamphetamine (2.0 mg/kg) in unilateral nigrostriatal-lesioned rats.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805014     DOI: 10.1007/BF00430763

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Progressive intensification of motor seizures produced by periodic electroconvulsive shock.

Authors:  D Ramer; J P Pinel
Journal:  Exp Neurol       Date:  1976-05       Impact factor: 5.330

2.  Progressive behavioral changes during chronic lidocaine administration: relationship to kindling.

Authors:  R M Post; R T Kopanda; A Lee
Journal:  Life Sci       Date:  1975-09-15       Impact factor: 5.037

Review 3.  Neurotransmitter interactions related to central dopamine neurons.

Authors:  K G Lloyd
Journal:  Essays Neurochem Neuropharmacol       Date:  1978

4.  Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

5.  Injections of dopaminergic, cholinergic, serotoninergic and GABAergic drugs into the nucleus accumbens: effects on locomotor activity in the rat.

Authors:  D L Jones; G J Mogenson; M Wu
Journal:  Neuropharmacology       Date:  1981-01       Impact factor: 5.250

6.  Electroconvulsive therapy in Parkinson's syndrome with "on-off" phenomenon.

Authors:  J Balldin; S Edén; A K Granérus; K Modigh; A Svanborg; J Wålinder; L Wallin
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

7.  A permanent change in brain function resulting from daily electrical stimulation.

Authors:  G V Goddard; D C McIntyre; C K Leech
Journal:  Exp Neurol       Date:  1969-11       Impact factor: 5.330

8.  Factors responsible for reduced pharmacological activity in rats of pentetrazol administered orally.

Authors:  H W Vohland; H Zufelde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-06       Impact factor: 3.000

9.  Repeated administration of subconvulsant doses of GABA antagonist drugs. I. Effect on seizure threshold (kindling).

Authors:  D J Nutt; P J Cowen; C C Batts; D G Grahame-Smith; A R Green
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--I. The effects of single and repeated bicuculline-induced seizures.

Authors:  D J Nutt; A R Green; D G Grahame-Smith
Journal:  Neuropharmacology       Date:  1980-09       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.